China mustn’t let an overdose of shady peptide exports get in the way of its thriving pharma sector
Beijing has cracked down on exports of the addictive painkilling drug fentanyl, but peptide exports seem to have a relatively free run. China should act against grey market supplies before they spell another opioid type crisis.
